Canadian Alcohol and Drug Use Monitoring Survey_ Summary of Results for 2012 - Health Canada

8/9/2019 Canadian Alcohol and Drug Use Monitoring Survey_ Summary of Results for 2012 - Health Canada

1/7

2 /8 /2015 Canad ia n A l coho l a n d

D r ug U s e Mo n it or in g

Survey:

Summa ry o f Resu lt s

fo r 2012

-

Hea lt h Canada

Haal lh S a i r i t é I

Iil

C E l | ‘ l i E | t : F £ | i

C a n a d a C a n a d a

H o m e > Hea l t h Con c e r n s > Drug Preven t ion &

Treatment >

D rug a nd A l c o h o l

Use

Sta t i s t i cs

Health Concerns

Summary

of

Results for 2 0 1 2

-

I n t r o duc t i o n

-

De ta i l ed

Tables

-

Cannab i s

Use

- Othe r Illicit

Drug Use

- Use a nd Abuse o f P s yc h o a c t iv e P h a rm a c e u tic a l

D r ugs

- Ha rms

Re l a ted

to Illicit Drug Use

- A l c o h o l

P re va l ence

o f A l c o h o l Use

Low- r i sk A l c o h o l Use

Ha rms Re l a ted

to

Othe r

People 's

A l c o h o l

Use

- De f i n i t i o n s

-

Re f e r e n c e I n f o rma t i o n

Introduction

The Ca n a d i a n

A l c o h o l

a n d

D rug Use

M o n ito rin g S u rv e y

( C ADUMS ) is

a n

a n nu a l g en e ra l popu l a t i on

s u r v e y

o f

a l c o h o l

a n d illicit

d rug

use a m o n g

Cana d i a n s aged 15

ye a r s a nd o l d e r that ran

f r om

2 0 0 8

t h r o ugh

2 0 1 2 . De r i ved f r om a n d similar to th e Ca n a d i a n Add i c t i o n

S u r v e y

( C AS ) o f 2 0 0 4 , CADUMS

was d e sig n ed to

p rov i de

de ta i l ed

n a t i o n a l

an d p ro v i n c i a l es t ima t es

o f

a l c o h o l - a n d d r ug - r e l a t ed

beha v i o u r s

a n d o u t c ome s . The f o l l ow ing

r epo r t presen t s r es u lts fr om

th e fifth a n d f i n a l

a n n u a l

CADUMS da ta c o l l e c t i o n ,

which

c omme n c e d in Fe bru a ry 2 0 1 2 . The Ca n a d i a n T oba c co , A lc o h o l a n d

D r ugs

Su r v e y

( C TADS )

wil l

r ep l ace

C A D UM S ;

it

was

l a u n c he d

in

2 0 1 3

an d

a sks ke y

ques t i ons

a b o u t

a l c o h o l an d

d rug

use on

a b ienn i a l

bas i s .

The

resu l t s

for

2 0 1 2 a re based on t e l e p hone i n t e r v i ews

with

1 1 ,0 90 re s po n d e n ts a cro ss a ll 10

p ro v i n ce s , which r e pr e s e n t 2 7 ,767 ,8 5 5

Ca n a d i a n

r es i den t s aged 15 yea r s a nd o l de r .

The

c u r r e n t

S umma r y o f Resu l t s

for

2 0 1 2 presen t s da t a

f r om

th e l a t e s t CADUMS

with

c o m p ar is o n s to CADUMS

2 0 1 1 a n d CAS 2 0 0 4 , to identify a n y

c h a n g e s

that ha v e t aken p lace in th e pa st 8 ye a r s . A

d i s c us s i o n o f

th e r es u lts fr om CADUMS

2 0 1 2 ,

d e ta i le d ta b le s

a n d

s ome de f i n i t i o n s

used in

th i s

r epo r t

a re

a lso p ro v i d ed .

Ma i n

indicators, overall,

C A S

2004, C A D U M S

2008-2012

Cannabis U se

C a n n a b i s -

l if e t i m e

4 4 . 5

4 3 . 9 4 2 . 4

4 1 . 5 39.4E| 4 1 . 5

C a n n a b i s - p a s t - y e a r 1 4 . 1

11.4El 1 0 . 6 l E l 1 0 . 7 | E l

9 . 1EE l 10.2 | I l

9 O a r n ; 7 c ? u t 2 c i | _ f ’ A ve r a g e

a g e of initiation

1 5 .6 y e a rs 1 5 .5 y ea rs 1 5 .6 y e a rs 1 5 .7 y e a rs 1 5 .6 y e a rs 16.1 yearsli]

Other Illicit

drug

u se

in past

year

C o c a i n e / C r a c k 1 . 9 1 . 6 1 . 2 l E l

o . 7 l G i 0.9lElTl

1 . 1 l E l

Q .

| |

| _ |

| _ | | _ |

| ‘I

ht tp:/ /www.hc-sc.gc.ca /hc-ps/d rugs-drogues/s ta t /_2012/sum mary -som maire-eng.php

http://www.hc-sc.gc.ca/index-eng.phphttp://www.hc-sc.gc.ca/hc-ps/index-eng.phphttp://www.hc-sc.gc.ca/hc-ps/index-eng.phphttp://www.hc-sc.gc.ca/hc-ps/drugs-drogues/index-eng.phphttp://www.hc-sc.gc.ca/hc-ps/drugs-drogues/index-eng.phphttp://www.hc-sc.gc.ca/hc-ps/drugs-drogues/index-eng.phphttp://www.hc-sc.gc.ca/hc-ps/drugs-drogues/index-eng.phphttp://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/index-eng.phphttp://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/index-eng.phphttp://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/index-eng.phphttp://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/index-eng.phphttp://www.hc-sc.gc.ca/hc-ps/drugs-drogues/index-eng.phphttp://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/index-eng.phphttp://www.hc-sc.gc.ca/hc-ps/index-eng.phphttp://www.hc-sc.gc.ca/index-eng.php


2/7


D ru g U s e Mo n ito rin g

Survey:


fo r 2012

-

Hea lt h Canada

0.4 ‘ 4 1 0.5 ‘ 4 1

peed

Ha l lu c in o g e n s ( ex c lu d i n g

sa l v i a )

Ha l l u c i n o g e n s ( in c lu d in g s a lv ia )

Ecs t a s y

Sa lv ia

Me t h amph e t am i n e / C r y s t a l

me t h

A n y

6 d r u g s a ( h a l l u c i n o g en s

exc l .

s a l v i a )

A n y 5 d r u g s

b

( h a l l u c i n o g en s exc l .

s a l v i a )

A n y 6 d r u g s a ( h a l l u c i n o g en s

i nc l .

s a l v i a )

A n y

5

d r u g s b ( h a l l u c i n o g en s

i nc l .

s a l v i a )

Drug related harms in

past

year

A n y

d ru g h a rm

to se l f

a m o n g

use r s

of

a ny d ru g

A n y

d ru g h a rm

to se l f

a m o n g

total

popu l a t i on

Alcohol

u se

Li f e t ime

Use

Pas t 1 2

mon t h

Use

A ve r a g e

a g e of initiation

for y ou t h

15

to

2 4

yea r s

0.8

0.7

1 .1

0.2

14.5

3.0

17.5

2.8

92.8

79.3

1 .1

‘L 1

l - l . I .

1.4

IZ-

_'|

12.1

3.9

21.7

2.7

90 . 2 1 - I

77.3

0

.

7 ‘L

0.9

0.9'l.l 1 : 1 .1

0

.9

‘L

5

5

11.0

Y ’ 1

2.0

11.1

2.11:

88.6

H

76.5

H

0.7

0 3 Li

IZ-

_'|

11.0.i

1 . 8 1 - I

11.1

2.0

17.0

2.1

88.91-i

77.0

0.5 ‘ I 4 1

0 .6 ‘L l

0

.9 ‘L

0 . 7 ‘L l

5

5

9.4 =

1_7

9.4 =

1.9

17.6

89.7

78.0

5

0.9

‘ 4 1

1 .1 ‘L l

0.6 ‘L l

5

5

10.6

‘I’

2.0

‘I ’

10.6

2.0

16.6

2.0'34i

91.0

78.4

1 5 .6 y e a rs 1 5.6 y ea rs

1 5 . 9

yea r s

1 5 . 9

yea r s

16.0

y e a rs 1 6.2 y e a rs

T

2011 Low-risk drinking guidelines (LRDG) - past 12 months

Exceeds

LRDG

c h r o n i c

Exceeds

LRDG a cu t e

Exceeds

LRDG c h r o n i c - a m o n g

d r i nke r s

Exceeds

LRDG a cu t e - a m o n g d r in ke rs

l ‘ - l

S am p le s iz e

I I nd i ca tes

that

t h e d i ff e re n c e between 2008 a n d 2004 is

s tat is t ica

M i

I nd i ca tes that t h e d i ff e re n c e between 2009

a n d

2004 is s tat is t ica

j-i

I nd i ca tes that t h e d i ff e re n c e

between 2010 a n d 2004 is

s tat is t ica

Ind i ca tes

that

t h e d i ff e re n c e between 2 0 1 1 a n d 2004 is

s tat is t ica

|


between

2012

a n d 2004

is s tat is t ica

: l:


between 2008 a n d 2009 is

s tat is t ica

14.3

10.2

18.0

12.9

15.0

10.9

19.8

14.3

14.5

11.7

19.1

15.5

y

s ign i f i c an t .

y s ign i f i c an t .




y


The re

a re

no

s t a t is t ic a l l y s i g n i fi c a n t d i f fe r e n c e s

between 2 0 1 0

a n d

2 0 0 9 in

th is table.

= I nd i ca tes that t h e d i ff e re n c e

between 2 0 1 1 a n d 2010

is s tat is t ica

y


: l : | =


between

2012

a n d

2 0 1 1 is s tat is t ica y s ign i f i c an t .

5 Es t ima t e supp ressed d u e

to h ig h samp l i ng

var iab i l i t y

L 1

E s ti m a te q ua li fi ed d u e

to h ig h

samp l i ng

var iab i l i t y ; i n te rp re t

w it h c a u ti o n

--

No

c ompa r a bl e e s t im a t e s .

14.5

10.5

19.1

13.8

14.4

10.1

18.7

13.1

14.4

9.9

18.6

12.8

l- l. i -

In 2008, th e

l i s t

o f s u b st a n c e s

u n d e r

ha l l u c i n ogens

i n c l u ded s alv ia a n d m a gic mus h r o om s ;

as

a r su t

th e

es t ima t e is

n o t compa rab le

to

2004,

2009-2012.

.3 Cann ab i s , c o c a i n e / c r a c k , speed ,

e c s ta s y , h a l lu c i n o g e n s ,

he ro i n

|; i Coca i n e / c r a c k , speed ,

e c s ta s y , h a l lu c i n o g e n s ,

he ro i n

Detailed

Tables

- Table 1 : Ma in 2 0 1 2 CADUMS i n d i ca t o rs by sex an d a ge

- D r ugs

- Table 2 :

Ma in

2 0 1 2 CADUMS i n d i ca t o rs by

p r o v i n c e - D r ugs

- Table 3:

Preva l ence

o f d r ug use a nd

ha rms ,

to ta l p o pu la t io n , CAS 2 0 0 4 , CADUMS 2 0 0 8

http:/ /www.hc-sc.gc.ca /hc-ps/d rugs-drogues/s ta t /_2012/summary-sommaire-eng.php

http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t1http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t1http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t1http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t1http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t1http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t1http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t1http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t1http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t1http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t1http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t1http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t2http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t2http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t2http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t2http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t2http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t2http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t2http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t2http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t2http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t2http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t1http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t2


3/7



Survey:


fo r 2012

-

Hea lt h Canada

2 0 1 2

- Table

4:

Preva l ence

o f

drug

use a nd

ha rms , by

age

g r oup ,

CAS 2 0 0 4 , CADUMS

2 0 0 8

-

2 0 1 2

- Table

5 : Preva l ence

o f drug use a nd

ha rms ,

by sex, CAS 2 0 0 4 , CADUMS 2 0 0 8

-

2 0 1 2

- Table

6:

Ma in 2 0 1 2 CADUMS i n d i ca t o rs by sex an d

a ge

A l c o h o l

- Table

7: Ma in

2 0 1 2

CADUMS

i n d i ca t o rs

by p r o v i n c e

A l c o h o l

- Table

8 :

Preva l ence

o f a l c o h o l use a nd

ex ceed i n g LRDG,

to ta l p o pu la t io n , CAS

2 0 0 4 ,

CADUMS 2 0 0 8 - 2 0 1 2

- Table

9:

Preva l ence

o f a l c o h o l use a nd

ex ceed i n g LRDG,

by a g e , CAS 2 0 0 4 an d CADUMS

2 0 0 8 2 0 1 2

-

Table

1 0 :

Preva l ence

o f

a l c o h o l

use

and

ex ceed i n g

LRDG,

by

sex ,

CAS

2 0 0 4

a nd

CADUMS

2 0 0 8 - 2 0 1 2

All

reported

increases

and

decreases

in

the text below are statistically significant

changes.

Th e words

statisticallysignificant will not

be

used s o a s to

allow

for more

readable text.

C a n n a b i s U se

The

p re va l e n ce

o f p as t-y e a r c annab i s use a m o n g


ye a r s an d o l d e r wa s 1 0 . 2

in

2 0 1 2 ,

u n c h a n g e d

f ro m 9.1 in 2 0 1 1 , bu t

lo w er th a n

in 2 0 0 4 (14.1 ). The re was an i n c rease in

pa s t - y e a r

c annab i s

use a m o n g

adu l t s aged

2 5 y e a r s an d o l d e r to

8 .4 in 2 0 1 2 fro m 6.7 in

2 0 1 1 ,

a n d

no

c h a n g e

f rom

2 0 1 1

a m o n g

y o u t h

aged

15

to

2 4

y ea rs . H o we ve r, th e

p re va l e n ce o f p a s t - y e a r

c annab i s

use a m o n g

y o u t h ( 2 0 . 3 ) r ema i n s h i g h e r t h an that o f adu l t s (8.4 ).

You ths

initiated

use

o f c annab i s

a t

an o l d e r a ge in

2 0 1 2 t h a n

in 2011(16.1 ve r s us 15 .6 yea r s ) .

The

p re va l e n ce

o f

p a s t - y e a r

c annab i s use in 2 0 1 2 was

lo w er th a n

in 2 00 4 a mo ng

ma l e s

(13 .7

ve r s us 1 8 . 2 ) , f em a l e s

(7.0

ve r s us 1 0 . 2 ) a n d y o u t h aged 15 to

24

ye a r s ( 2 0 . 3 ve r s us

37 .0 ) , with

th e

p re va l e n ce

a m o n g

ma l e s r em a i n in g tw ic e

as h igh as that o f

f em a l e s

(13 .7

ve r s us 7.0 ,

r e spec t i v e l y ) .

Preva l ence

a m o n g

adu l t s

aged 2 5 ye a r s a nd o l d e r was u n c h a n g e d

be tween 2 0 1 2 a n d 2 0 0 4 .

Prov i nc i a l

p re va l e n ce

o f

p a s t - y e a r

c annab i s use r a n ged f ro m 8 .5 in New B ru n swic k to 1 3.8 in

Bri t ish Co l umb i a . Th e re we re no yea r—to—year c h a n g e s in p ro v i n c i a l ra tes o f c annab i s use . Each

p rov i n ce ' s pa s t - y e a r

c annab i s

p re va l e n ce

was

c ompa r e d

with

th e a v e r a g e

p re va l e n ce

for

th e

n i ne

r em a i n in g p ro v in c e s .

Of

th e se , o n ly Br it is h Co lumb i a

shows h i g h e r th a n a ve ra ge

p re va l e n ce .

Other Illicit Drug

Use

In

2 0 1 2 , pa s t - y e a r use o f

th e m os t c om m o n l y r epo r t ed illicit d r u g s

after

c annab i s was es t ima t e d to

be a b o u t

1 for

ea c h

( e c s t a s y (0.6 ),

h a llu c in o g e ns in c lu d in g s a lv ia

(1.1 ) a nd c o c a i n e

o r

c r a c k

(1.1 )).

Pas t - ye a r

use

o f spee d , m e th a m ph e ta m in e o r he ro i n

is

n o t r epo r t ab l e . Th e re we re no

c h a n g e s

in

p re va l e n ce

o f

a n y o f

t h e s e d r u g s individually,

be tween 2 0 1 2

a n d 2 0 1 1

o r be tween 2 0 1 2

a n d 2 0 04 .

Use o f a t le as t

on e

o f five illicit d r u g s exc l ud i ng c annab i s [c oc a in e o r c ra c k, s pe ed , e c s t a s y ,

h a l l u c i n o gen s (in c lu d in g s a lv ia ) o r h e ro in ]

was

r epo r t ed

by

2 . 0 o f

Cana d i a n s

a n d

is

n o t

different

f rom 2 0 1 1 (1.9 ). The r epo r t ed ra te o f such use by

ma l e s

(3.1 ) was a lm o s t triple that r epo r t ed

by

f em a l e s

(1.1 ),

whi le th e

ra te

o f

use

by y o u t h (6.5 )

was

five t im e s h ig h er th an

that

r epo r t ed

by

adu l t s

(1.2 ). R a tes a re n o t c o m p a ra ble

to

2 0 04 be ca use

sa l v i a

was n o t in c lu d e d in th e

CAS .

Users

o f illicit d ru g s we re

asked

h ow e as y it

wou l d

be

for

t h em

to g e t that spec i f i c d rug if t h e y

wan ted s ome

now .

M o st u se rs

o f

c annab i s (84.5 )

an d

c o c a i n e (77.8 ) sa id

it

would

be

e as y o r

ve r y

e a sy to g e t.

Resu l t s for o t h e r d rugs a re n o t

repor tab le

d ue

to

lo w n u m be rs a nd

s m a ll s a m ple

s i ze .

U se a n d Ab u s e of Psychoactive

Pharmaceutical

D r u g s

ht tp: / /www.hc-sc.gc.ca /hc-ps/d rugs-drogues/s ta t /_2012/summary-sommaire-eng.php

http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t5http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t5http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t5http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t5http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t5http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t5http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t5http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t5http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t5http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t5http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t5http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t5http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t5http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t5http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t5http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t5http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t6http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t6http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t6http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t6http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t6http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t6http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t6http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t6http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t6http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t6http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t6http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t6http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t7http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t7http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t7http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t7http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t7http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t7http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t7http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t7http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t7http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t7http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t8http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t8http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t8http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t8http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t8http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t8http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t8http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t8http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t8http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t8http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t8http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t8http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t8http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t8http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t8http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t8http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t7http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t5http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t6http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t8http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4


4/7



Survey:


fo r 2012

-

Hea lt h Canada

CADUMS i n c l u de s qu e s tio n s r e la t in g to th e abuse o f th re e c l asses

o f

p s y c h o a c tiv e p h a rm a c e u t ic a l

d rugs . The

t h ree c l asses

o f d r u g s

a re : op io id

pain r e l i eve r s , ( s uch as Pe r c o d a n® ,

Dem e r o l ®

an d

OxyContin®); s t imu l an t s , ( s uch as Ritalin®, Con c e r t a® ,

Adde r a l l ®

a nd Dexedrine®); an d

t r anqu i l l i ze r s a nd

seda t i v e s ,

( s uch

as Valium®,

Ativan® a nd

Xanax®) . W h ile th e se

d rugs a re

presc r ibed for t h e r apeu t i c

purposes ,

t h e y h a v e th e po t e n t i a l to be abused d ue

to

their p s y c h o a c t i v e

p rope r t i e s .

To

p rov i de

a base l i ne on o ve r a l l use,

i n c l ud i ng

t h e r apeu t i c use an d

abuse ,

r e sponde n t s

were asked whe t h e r o r n o t

t h e y had

used op io id pain r e l i eve r s ,

s t imu l an t s ,

o r s e d a tiv e s .

A mo n g

t h o s e who had used t h e s e

d r ugs ,

further

ques t i ons were a ske d to de t e rm i n e

whe t h e r th e d r u g s

were used

for

r e a s o n s

o t h e r

t h an

for

presc r ibed t h e r apeu t i c purposes .

A l t h o ugh th e o ve r a l l

ra te o f

p s y c h o a c tiv e p h a rm a c e u t ic a l

use a m o n g


y e a r s

and

o l d e r wa s u n c h a n g e d be tween 2 0 1 2 (24.1 ) a nd 2 0 1 1 (22.9 ), th e ra te o f such use a m o n g you t h

in c re a se d to 24.7 in 2 0 1 2 f r om 17.6 in 2 0 1 1 . Use o f p s y c h o a c tiv e p h a rm a c e u t ic a ls wa s similar

be tween y o u t h aged 15 to

2 4 ye a r s an d

adu l t s aged

2 5 ye a r s a n d o l d e r

( 23 .9 ) wh ile p re v a le n c e

was h i g h e r a m o n g

f ema l e s

(26.7 ) t h an

ma l e s

(21.3 ).

In

2 0 1 2 ,

o f Cana d i a n s aged 15 ye a r s a n d

o l d e r who

i n d i c a t e d t h e y

had

used a psychoa c t i v e

pha rmaceu t i c a l

in th e pa st

y e a r ,

6.3 (or

41 0 , 0 0 0 Cana d i a n s , co r r e spond i n g to

1 . 5 o f th e t o t a l

p opu l a t i o n ) r epo r t ed t h e y abused such a d rug

( i . e .

used it

for

th e expe r i e n ce , th e f ee l i ng it

c au se d, to g e t h igh o r

for

othe r r e a s ons ) . These ra tes

o f

abuse

a re

h ig h e r th a n in

2 0 1 1 ,

when

3 .2

o f use r s

( c o r r e spond i n g

to

0 .7

o f th e to ta l p o pu la t io n ) r epo r t ed t h e y ha d abused su c h

a

d r u g .

H i g h e r

ra tes

o f

a bu se we re

a lso obse r v e d

a mo n g m a le use rs

in

2 0 1 2 ,

with 7.8

( c o r r e spond i n g

to

1 .6

o f

th e

ma l e popu l a t i o n )

a bu sin g th e se

d r u g s

c om pa re d to

2 0 1 1

ra tes

o f

3 .1

a n d 0 .6 , r e sp e c tiv e ly . The re was

no

c h a n g e in

p re va l e n ce

a m o n g

adu l t s

aged 2 5 ye a r s a nd

o l de r ,

wh i le

c h a n g e s a m o n g y o u t h a nd fe m a le s c a nn o t be es t ima t e d because

their

ra tes

for 2 0 1 1

a re

n o t r epo r t ab l e .

Opioid

Pa in

Relievers

Of

th e

t h ree

ca t e go r i e s o f pha rmaceu t i c a l s ,

op io id

pain r e l i e ve rs were th e m os t c om m o n l y used in

2 0 1 2 ,

with

o n e

in s ix (16.9 ) Cana d i a n s aged 15 ye a r s

a nd o l d e r

r epo r t i ng

their use

in th e 12

m o nth s pre ce din g th e

s u r v e y .

Th e re we re

no c h a n g e s

in th e

p re va l e n ce

o f

p a s t - y e a r

use o f

op io id

pain r e l i e ve rs c ompa r e d

with

2 0 1 1 ,

n o r were t he re a n y

within-year

d i f f e r en c es , by

sex

o r

a ge

g roup .

A mo n g

users

o f

op io id

pain r e l i eve r s ,

5 . 2

(or 243 , 0 00

C a n a d i a n s r ep re s e n tin g 0 .9

o f th e t o t a l

p opu l a t i o n ) r epo r t ed

abusing

t h em . The

c h a n g e

f rom

2 0 1 1

c a n n o t be es t ima t e d because th e

ra te

for 2 0 1 1

is n o t r epo r t ab l e .

A mo n g a d u l t use r s o f

op io id pain

r e l i eve r s ,

3 .1 ( co r respond i ng to

0 . 5 o f th e to ta l a d u lt p op ula tio n ) abused such d r ugs , an i n c rease o v e r th e 2 0 1 1

ra tes

( 1 . 3

a m o n g u se rs a nd

0 . 2 wi th in th e

t o ta l p o p u la t io n ) .

A

ques t i on

was a d d e d in 2 0 1 2 to

de t e rm i n e

whe t h e r use rs o f

op io id

pain r e l i e ve rs

ta m p e re d w ith

their

med i c a t i o n pr i o r to use : D u rin g th e pa st12 mon t h s d id y o u

e ve r ta m pe r

with a pain reliever

p ro du c t be fore

ta kin g it, for

examp l e ,

c rush t ab le t s

to s wa llo w, s n o rt o r in je c t?

When tam pe r in g

was a d d e d to th e ex i s t i ng definition o f abuse , it d id n o t r e su l t in a n y c h a n g e in pain reliever abuse

c ompa r e d with

2 0 1 1 ,

n o r were t he re a n y d i f f e r en c es in th e 2 0 1 2 resu l t s be twe en th e

ex i s t i ng

definition

o f

abuse

an d

that definition

w ith tam p e r in g

a d d e d .

Stimulants

The re was an i n c rease in th e use o f s tim u l a n ts be tween 2 0 1 2 (1.5 ) a nd 2 0 1 1 (0.9 ) a m o n g


ye a r s a n d o l de r .

P re va l ence

a m o n g

y o u t h aged 15 to

2 4 ye a r s

(4.9 )

wa s

h i g h e r t h an a m o n g

adu l t s aged

2 5 ye a r s an d o l d e r (0.9 ), whi le

t he re

wa s

no

d i f f e r ence in

p re va l e n ce be tw ee n m a le s (1.9 ) a n d f ema l e s (1.1 ). Th e re we re no c h an g es be tw ee n 2 0 1 2 a nd

2 0 1 1

in th e pre va le nc e o f

pa s t - y e a r use

o f

s t imu l an t s by sex

o r

a ge

g roup .

For ty

pe r cen t

(40.1 ) o f peop le who used s t imu l an t s (or 1 68 ,0 0 0 C a n a d ia n s,

r ep resen t i ng

0 .6 o f

th e

to ta l p o pu la t io n ) r epo r t ed abusing

t h em .

Th is ra te

is u n c h a n g e d f rom

2 0 1 1

when 27.4

o f



5/7



Survey:


fo r 2012

-

Hea lt h Canada

use r s

r ep o rte d a b us in g s t imu l an t s . The 2 0 1 2 ra tes o f abuse

for

th e t o t a l popu l a t i on a n d a m o n g

u se rs by sex

o r

a ge g r oup ,

c a n n o t

be

c om pa re d to

th e 2 0 1 1

ra tes

because th e 2 0 1 1

ra tes

a re n o t

r epo r t ab l e .

Sedafives

The re

were no c h a n g e s in

th e

p re va l e n ce

o f p as t- y e a r use o f seda t i v e s

(10.2 )

by

Cana d i a n s

aged 15 ye a r s a nd o l de r . The re wa s h i g h e r

p r e va l e n ce

o f such

use

by f ema l e s (12.8 ) c ompa r e d

with ma l e s

(7.5 ),

an d no d i f f e r en c e be tween y o u t h a n d adu l t s .

Abuse

o f s e d a tiv e s, measu r e d by

use

for

th e

expe r i e n ce ,

th e

fe e lin g th e y

c a u s e

o r

to

g e t

h i g h ,

is

n o t

r epo r t ab l e

d ue

to th e

lo w

numbe r s o f users a n d s m all s am ple s ize.

Other

The

abuse

o f d e xtro m e t h o rp h a n , an a c tiv e in g re d ie n t f o u n d in ma n y over-the-counter c o u g h -

supp re ssan t

co ld

med i c i n e s ,

is n o t r epo r t ab l e d ue to th e lo w n u m be rs o f

use r s

a nd s m all s am ple

s i ze .

Harms

Related

to

Illicit D r u g U se

In 2 0 1 2 ,

2 . 0

o f


ye a r s a n d o l d e r r epo r t ed

expe r i enc i ng

a t le as t o n e ha rm in

th e pa st

y e a r

d ue

to

their

illicit

drug

use ,

a

ra te u nc ha n ge d

f r om

2 0 1 1

(1.8 )

an d

f r om

2 0 0 4

(2.8 ).

The

p re va l e n ce

o f

r epo r t ed ha rm

d ue

to

their own

drug

use was

four t im e s h ig he r

a m o n g

y o u t h aged 15 to

2 4

ye a r s (5.5 )

th a n a d u lts

aged 2 5 ye a r s an d o l d e r (1.4 ). A m o n g c u r r e n t

use r s

o f a ny d ru g, i n c l ud i ng abuse o f p sy c h o a c tiv e p h ar m a c eu tic a ls s i n ce

2 0 0 8 ,

th e re po rte d ra te

o f p as t-y e a r ha rm ha s n o t c ha ng ed s in ce 2 0 04,

with

app r ox ima t e l y o n e in

s ix (16.6 )

use r s

r epo r t i ng

hav i n g

expe r i enced

so me h arm in th e pa st year d ue to

their

d rug use .

Alcohol

Prevalence of Alcohol U se

In 2 0 1 2 ,

78 .4 o f Cana d i a n s

repo r t ed

d r i nk i ng

a l c o h o l in

th e pa st y e a r , a

ra te similar

to

that

r epo r t ed

in

2 0 1 1

(78.0 ).

Th ere wa s,

howeve r ,

a

de c r e ase

in

pa s t - y e a r

a l c o h o l

use

a m o n g

y o u t h

15 to

2 4

ye a r s

o f a ge

c om pa re d to CAS in 2 0 0 4 , f ro m 8 2 .9 to 70 . 0 in 2 0 1 2 . S im i l a r to p rev i ous

yea r s , in

2 0 1 2 , a

h i g h e r

pe r c e n t age o f

ma l e s

t han

f em a l e s

r epo r t ed pa s t - y e a r a l c o h o l use ( 82 .7

ve r s us 74.4 ,

r e spec t i v e l y )

w hile th e

p re va l e n ce

o f past-year d r i nk i ng a m o n g adu l t s aged 2 5

ye a r s an d o l d e r

(80.0 )

wa s

h ig h e r th a n

a m o n g

y o u t h (70.0 ).

Prov i nc i a l

ra tes

o f

cu r r e n t

d r i nk i ng r a n ged

f ro m 72 .3

in Nova

S c otia to 8 2 . 1

in

Quebec . Each

p rov i n ce ' s

pa s t - y e a r

a l c o h o l

p re va l e n ce

was c ompa r e d

with

th e a ve ra g e

for

th e n ine

r ema i n i n g

p rov i n ces .

Th ree

p ro v i n ce s

ha d

l owe r th a n a ve ra ge p re va l e n ce (Nova Sco t i a ,

New

Brunsw i ck

(73.8 )

a nd Prin ce E dwa rd I s l and (74.0 ))

whi le th e p re va l e n ce

o f p as t-y e a r a l c o h o l use in

Quebec wa s h i g h e r t h an

a v e r a g e .

Preva l ence

o f p as t- y e a r

a l c o h o l

use s i n ce 2 0 1 1

was u n c h a n g e d

for a ll

p rov i n ces .

Low-risk

Alcohol

U se

In No v em b e r 2 0 1 1 , th e Ca n a d i a n fe d e r a l, p ro v in c i a l, a nd territorial

hea l t h

m in i s t e rs r e ce i ved

Canada ' s

Low-Risk

A l c o h o l

Dr i nk i ng

Guidelinesl

(LRDG) , which

c o n s i s t o f five gu i d e l i n e s a nd

a

se r ies o f t ips .

Gu i d e l i n e s

a nd 2 , an d acu t e an d c h r on i c

e f f e c t s , a re

exp la i ned in th e de f i n i t i o n s

sec t i on

be low. Pe ople wh o d r in k w ith in th e l ow- r i sk a l c o h o l d r i nk i ng

gu i d e l i n e s c o n s ume no mo r e

th a n th e re co m m en de d quan t i t y o f a l c o h o l wi th in th e

n umbe r

o f d a y s spec i f i ed ,

whe reas

t hose who

e xc ee d th e gu i d e l i n e s c o n s ume mo r e a l c o h o l t h an r e c ommende d wi th in th e s t a t ed

t i me f r ame .

The bas i s o f th e

LRDG is

re po r te d a lc o h o l

con sump t i o n

in th e

7 d a y s

pr i o r to

th e s u r v e y . Because

th is in fo rm a t io n is ava i l ab l e

for

CAS 2 0 0 4 an d ea c h

y e a r

o f CADUMS ( 2 0 0 8 - 2 0 1 2 ) , e x c e e d a n c e o f



6/7


7/7



Survey:


fo r 2012

-

Hea lt h Canada

Repo r ted use in th e 1 2 m o nth s pre ce din g th e i n t e r v i ew.

Prevalence

The

p ropo r t i on

o f a g r oup o r p o pu la t io n

repo r t i ng

th e i n d i ca t ed beha v i o u r o r

o u t c ome ,

u sua l l y

exp ressed as

a pe r c e n t age .

Reference Information

The Ca n a d i a n A l c o h o l an d D rug Use

M o n ito rin g S u rv e y

( C ADUMS )

is

a n

a n n u a l

ge ne r a l popu l a t i on

su r ve y o f

a l c o h o l

a n d

illicit

d rug

use

a m o n g

Cana d i a n s

aged

15

an d

o l d e r ,

sponso r e d

by

Hea l t h

Ca n a d a . It was de ve l oped in

c o l l abo r a t i o n

with th e

Cen t r e for

Add i c t i o n s

a nd

Men t a l Hea l t h

( CAMH ) , th e Cen t r e

for

Add i c t i o n Rese a r c h

-

Bri t ish Co lumb i a

( CAR -BC ) ,

Alber ta

H e a lth S e rv ic e s

(formerly,

Alber ta

A l c o h o l a n d D rug Abuse Comm i s s i o n ) , Man i t oba Hea l t h , th e Cen t r e québeco i s

de

l u t te

a u x d ép en d a n ce s (CQLD) ,

a nd th e C a n a d ia n C e n tre on

Subs t an ce

Abuse ( CCSA ) . Des i g n ed

to

p rov i de a n n u a l na t i o n a l

a nd p ro v i n c i a l e s tim a te s o f a l c o h o l a nd d r ug - r e l a t ed

beha v i o u r s

and

o u t c ome s , CADUMS

was

l a u n c he d in Apr i l 2 0 0 8 .

With in

e ach

y e a r ,

th e

ta rg e te d n u m be r

o f CADUMS i n t e r v i ews

to be

c o n d u c t e d by

t e l e p hone is

1 , 0 0 8 pe r p ro v i n ce ,

ra n d o m ly s e le c te d

to p roduce a

n a tio n a l s u rv e y

o f

1 0 , 0 8 0

in t e rv iew s a n n u a l ly .

Due

to me t h o d o l o g i c a l is su e s, th e territories

a re

n o t in c lu d e d

in

th e s u r v e y .

Prov i n ces

h a v e th e

op t i on to

bu y a d d i tio n a l in t e rv iew s to a l l ow for

more

d e ta ile d a n a ly s is o f

resu l t s

wi th in their

jurisdiction.

Fo r

th e

2 0 1 2

c a le n d a r y e a r,

th e p ro v in c e

o f Bri t ish

C o lu m bia a rra n g ed

for their

s amp l e

to be in cre ase d to 2 ,0 0 8 . Th is r esu l t ed in

a f i n a l

s amp l e o f 1 1 ,0 90 re s po n d e n ts in

2 0 1 2 ,

r ep resen t i ng

app r ox ima t e l y

27,767,855 Cana d i a n s aged 15

an d o l de r . The re spo n se ra te for

th e

2 0 1 2 CADUMS wa s 39 .8 , a de c r e ase fro m 45 .5 in 2 0 1 1 , d ue in

pa r t

to th e

ce ssa t i o n

o f

in t ro d u c t o ry le t te r s

mai l e d

to

po t e n t i a l

r e sponde n t s . Fo r

th e

pu rposes o f th is

re po rt o n ly

un i v a r i a t e

a n d b i va r i a t e

ana l y se s

were

c o n d u c te d , w ith

statistical s i g n i f i c a n c e be ing

de t e rm i n ed

by

con f i d e n ce i n t e r v a l o ve r l a p

for

2 0 1 2 to 2 0 0 4

compa r i s o n s ,

an d t—tes t ing

for

2 0 1 2 to 2 0 1 1

c ompa r i s o n s . The da t a

presen t ed in

th i s

r epo r t

h a v e been

we igh ted

to

a l l ow th e resu l t s

to be

gene ra l i zed

to th e Ca n a d i a n popu l a t i on us i ng th e Ca n a d i a n Census 2 0 1 1 . A t e c h n i c a l gu i de

with

further

de ta i l s

on

th e s urv e y m e th o d o lo g y

wil l

be

ava i l ab l e upon

r eques t

after

Sep t embe r 1 , 2 0 13 .

Fo r

more

i n f o rma t i o n

a b o u t

th e

s u r v e y

an d

it s r esu l t s ,

p lease

wri te to

th e O ff ic e o f R e se arc h a nd

Su r v e i l l a n c e ,

Con t ro l l ed

Subs t an ce s an d Tobacco D i r e c t o r a t e , Hea l t h Ca n a d a , 1 5 0 Tunne y ' s Pas tu re

Dr i veway , A d d re ss Lo c a to r 0 3 0 1 A , Ot t awa ,

ON ,

K1A

0K9 ,

o r

send a n

e -m a i l re qu e st to

C A D UM S -

ESCCAD@hc—sc .gc . c a .

l Ca n a d i a n

Cen t r e

o n

Sub s t a n c e Abuse .

'5 '

Ca n a d a ' s

Low -R i sk

A l co h o l D r in k in q

Gu ide l i nes [brochure],

2 0 1 3 .

A cc es se d M a y 2 4 , 2 0 1 3 .

Date Modified:

2014-04-08

mailto:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]://www.ccsa.ca/Resource%20Library/2012-Canada-Low-Risk-Alcohol-Drinking-Guidelines-Brochure-en.pdfhttp://www.ccsa.ca/Resource%20Library/2012-Canada-Low-Risk-Alcohol-Drinking-Guidelines-Brochure-en.pdfhttp://www.ccsa.ca/Resource%20Library/2012-Canada-Low-Risk-Alcohol-Drinking-Guidelines-Brochure-en.pdfhttp://www.ccsa.ca/Resource%20Library/2012-Canada-Low-Risk-Alcohol-Drinking-Guidelines-Brochure-en.pdfhttp://www.ccsa.ca/Resource%20Library/2012-Canada-Low-Risk-Alcohol-Drinking-Guidelines-Brochure-en.pdfmailto:[email protected]

Documents

Canadian Alcohol and Drug Use Monitoring Survey_ Summary of Results for 2012 - Health Canada